[
  {
    "ts": "2025-11-18T06:16:51+00:00",
    "headline": "Johnson & Johnson Expands Oncology Pipeline with $3.05 Billion Halda Acquisition",
    "summary": "Deal adds new prostate cancer candidate and supports J&J's long-term oncology strategy.",
    "url": "https://finance.yahoo.com/news/johnson-johnson-expands-oncology-pipeline-061651954.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "4e3f32bc-fbb1-374b-b5f9-bb5c1ae32e68",
      "content": {
        "id": "4e3f32bc-fbb1-374b-b5f9-bb5c1ae32e68",
        "contentType": "STORY",
        "title": "Johnson & Johnson Expands Oncology Pipeline with $3.05 Billion Halda Acquisition",
        "description": "",
        "summary": "Deal adds new prostate cancer candidate and supports J&J's long-term oncology strategy.",
        "pubDate": "2025-11-18T06:16:51Z",
        "displayTime": "2025-11-18T06:16:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/a631149e008fe04bcad182a629a22c2e",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nQahFoVt6_qKzx8G6FoELg--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a631149e008fe04bcad182a629a22c2e.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yScmCasUkPZyvdIPPU4j.w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a631149e008fe04bcad182a629a22c2e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-expands-oncology-pipeline-061651954.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-expands-oncology-pipeline-061651954.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-18T10:13:07+00:00",
    "headline": "Johnson & Johnson to acquire Halda Therapeutics for $3.05bn",
    "summary": "The acquisition brings Halda's candidate HLD-0915, a clinical-stage treatment for prostate cancer, into J&J's oncology portfolio.",
    "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-halda-therapeutics-3-05bn/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "8a01d1ca-5f52-3f19-8662-2185fff4ad1d",
      "content": {
        "id": "8a01d1ca-5f52-3f19-8662-2185fff4ad1d",
        "contentType": "STORY",
        "title": "Johnson & Johnson to acquire Halda Therapeutics for $3.05bn",
        "description": "",
        "summary": "The acquisition brings Halda's candidate HLD-0915, a clinical-stage treatment for prostate cancer, into J&J's oncology portfolio.",
        "pubDate": "2025-11-18T10:13:07Z",
        "displayTime": "2025-11-18T10:13:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/6edd94881ba09d9179e562cf8710320c",
          "originalWidth": 1440,
          "originalHeight": 811,
          "caption": "The acquisition brings Halda's lead candidate",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QuCpXe9bm4NWWNIQ_BW7eg--~B/aD04MTE7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/6edd94881ba09d9179e562cf8710320c.cf.webp",
              "width": 1440,
              "height": 811,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aJ03hgRyJ1AB0gK8mdqanQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/6edd94881ba09d9179e562cf8710320c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-halda-therapeutics-3-05bn/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-acquire-halda-therapeutics-101307944.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-18T09:27:00+00:00",
    "headline": "The Zacks Analyst Blog Highlights Eli Lilly, Johnson & Johnson and Adverum",
    "summary": "Lilly shines for growth seekers while J&J offers steady, lower-risk stability as both pharma giants advance pipelines and post rising estimates.",
    "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-eli-092700816.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "cb798202-0361-33be-862a-674ba250326d",
      "content": {
        "id": "cb798202-0361-33be-862a-674ba250326d",
        "contentType": "STORY",
        "title": "The Zacks Analyst Blog Highlights Eli Lilly, Johnson & Johnson and Adverum",
        "description": "",
        "summary": "Lilly shines for growth seekers while J&J offers steady, lower-risk stability as both pharma giants advance pipelines and post rising estimates.",
        "pubDate": "2025-11-18T09:27:00Z",
        "displayTime": "2025-11-18T09:27:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MjuR.4zEKm0FgKsxK.lBKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.VCDKzJSEg_sv.1sSAJrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-eli-092700816.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-eli-092700816.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]